QNTM Labs®

QNTM Labs® is a cutting-edge contract laboratory specializing in chemical and biological analysis, contract research, development, and regulatory compliance applications for pharmaceutical companies. Based in Odense, Denmark, the company is committed to pioneering innovative analytical methods while upholding the highest standards of quality to establish new industry benchmarks. With the global spotlight increasingly focused on data quality, QNTM Labs is dedicated to enhancing transparency and facilitating access to robust scientific analysis by collaborating closely with global pharmaceutical industry stakeholders through analytical testing. The company, established in 2020, operates within the biotechnology, industrial, and pharmaceutical sectors. Its most recent milestone is the Series A investment secured on 17 November 2022, with Intrinsic Capital Partners contributing to the company's growth trajectory. Overall, QNTM Labs is emerging as a key player in the pharmaceutical analytical services market, leveraging its innovative approach to data analysis and commitment to quality to create lasting industry impact.